Interested in Learning How the Microbiome Impacts Drug Discovery?


     
Coming to the 2017 Translational Microbiome Conference? Attend the Translational Microbiome Conference in Boston this April to learn how the microbiome is impacting the drug discovery industry. This industry-leading, three-day conference "focuses on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make this space successful."

Taconic Biosciences — the only commercial provider of germ-free mice — will sponsor, speak, and conduct a workshop at this year's conference.

Application Scientist Randi Lundberg will present "Mice as Translational Models: Planning a Fecal Microbiota Transplantation Study," covering practical considerations and pitfalls when planning experiments using gnotobiotic mice generated by fecal microbiota transplantation.

We hope to see you there!
“There are many experimental design variables in conducting in vivo studies; adding the complexity of the microbiome makes these studies even more challenging.”
–Dr. Alex Maue

Microbiome Study Design Workshop

Microbiome studies are opening immense opportunities for discovering new therapies, from bioactive molecules to fecal transplants – but how can you assure reliable results in support of your research and drug development goals?

Attend our open pre-conference workshop, "Navigating the Challenges of Studying the Microbiome in Mouse Models: Design, Execution and Utility", for the latest in microbiome study design best practices:

  • Selecting appropriate models for in vivo experiments
  • Designing successful microbiome association studies
  • Understanding the potential of mouse microbiome studies in drug discovery
Moderated by Taconic's Dr. Alexander Maue, Director of Microbiome Products and Services, the workshop will feature Dr. William DePaolo, Associate Professor of Medicine and the Lynn M. & Michael D. Garvey Endowed Chair in Gastroenterology at the University of Washington. Dr. DePaolo is also Director, Center for Microbiome Sciences & Therapeutics (CMiST). Assisting Dr. DePaolo will be a panel of scientists with diverse perspectives and includes Dr. James Matumba, co-founder Commense, Inc., Dr. Beth McCormick, professor and vice chair, University of Massachusetts Medical School, Founder Center for Microbiome Research and Dr. Phil Dubé, Field Application Scientist, Taconic Biosciences.

The workshop is open to all Translational Microbiome Conference attendees, but space is limited.

Related White Paper Download the Taconic Biosciences' White Paper: